Timely engagement is the key to expanding the use of companion diagnostics.
Peter Keeling
Advertisement
Peter Keeling is CEO of Diaceutics Group. He can be reached at peter.keeling@diaceutics.com or 011 44 2890 875559.
Articles by Peter Keeling
Partnerships between pharmaceutical (Rx) and diagnostic (Dx) companies are difficult to achieve because most managers don't understand what it takes to make them work.
Advertisement
Latest Updated Articles
Early Engagement with Medical LaboratoriesPublished: March 1st 2013 | Updated:
- How to Make Rx-Dx Alliances Work
Published: July 1st 2003 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
4
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
5
